A pilot study of resistance to aspirin in stroke patients

Journal of Clinical Neuroscience

Volumn 15, Issue 11, 2008, Pages 1204-1209

  Bennett, Daniel ^a   Yan, Bernard ^a   MacGregor, Lachlan ^a   Eccleston, David ^a   Davis, Stephen M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aspirin resistance; Ischaemic stroke; Transient ischaemic attack

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; AUSTRALIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTION TEST; HOSPITAL; HUMAN; MALE; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STROKE; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ASPIRIN; AUSTRALIA; DRUG RESISTANCE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; STROKE;

EID: 53349164100     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.01.006     Document Type: Article

References (21)

1. Collaboration A.T. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
2. Algra A., and van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry 60 (1996) 197-199
3. Gum P.A., Kottke-Marchant K., Welsh P.A., et al. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41 (2003) 961-965
4. Eikelboom J.W., Hirsh J., Weitz J.I., et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105 (2002) 1650-1655
5. Wang J.C., Aucoin-Barry D., Manuelian D., et al. Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA. Am J Cardiol 92 (2003) 1492-1494
6. Mueller M.R., Salat A., Stangl P., et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 78 (1997) 1003-1007
7. Harrison P., Segal H., Blasbery K., et al. Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry. Stroke 36 (2005) 1001-1005
8. Chen W.H., Lee P.Y., Ng W., et al. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43 (2004) 1122-1126
9. Adams H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke - definitions for use in a multicenter clinical-trial. Stroke 24 (1993) 35-41
10. Bamford J., Sandercock P., Dennis M., et al. Classification and natural-history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991) 1521-1526
11. Coleman J.L., Wang J.C., and Simon D.I. Determination of individual response to aspirin therapy using the accumetrics Ultegra RPFA-ASA System. Point of Care: The Journal of Near-Patient Testing & Technology 3 (2004) 77-82
12. Lee S.J., Kim T.H., Kim J.G., et al. The prevalence of aspirin resistance and related factors in patients with ischemic stroke using the rapid platelet function assay. Stroke 38 (2007) 524-4
13. Grundmann K., Jaschonek K., Kleine B., et al. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. J Neurol 250 (2003) 63-66
14. Grotemeyer K.H., Scharafinski H.W., and Husstedt I.W. 2-Year follow-up of aspirin responder and aspirin nonresponder - a pilot-study including 180 poststroke patients. Thromb Res 71 (1993) 397-403
15. Gurbel P.A., Bliden K.P., Chaganti S., et al. Effects of diabetes on the prevalence of aspirin resistance during low dose aspirin therapy. J Am Coll Cardiol 49 (2007) 230A
16. Fateh-Moghadam S., Plockinger U., Cabeza N., et al. Prevalence of aspirin resistance in patients with type 2 diabetes. Acta Diabetol 42 (2005) 99-103
17. Friend M., Vucenik I., and Miller M. Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ 326 (2003) 82-83
18. Mirkhel A., Peyster E., Sundeen J., et al. Frequency of aspirin resistance in a community hospital. Am J Cardiol 98 (2006) 577-579
19. Alberts M.J., Bergman D.L., and Molner E. Antiplatelet effect of aspirin in patients with cerebrovascular disease. J Vasc Surg 39 (2004) 1142
20. Hankey G.J., and Eikelboom J.W. Aspirin resistance. Lancet 367 (2006) 606-617
21. Cotter G., Shemesh E., Zehavi M., et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?. Am Heart J 147 (2004) 293-300